Filing Flows

Filing Flows › Consumer Staples › Solesence (SLSN)

Solesence (SLSN) earnings and revenue breakdown

Latest: Q2 2026 · 10-Q filed Aug 19, 2026 · Solesence (SLSN) Q2 2026 earnings results →

Q2 2026 Revenue down 25% year over year to $15.3M · 1¢ of every $1 of revenue lost · operating margin 0.8%

Solesence made $15.3M in Q2 2026 (-25% Y/Y): Product $15.3M, Product and Service, Other $46K, Advanced Materials $41K. Operating margin 0.8%, net loss $158K. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Aug 19, 2026.

Revenue$15.3M
Year over year-25%
Operating margin0.8%
Net earnings−$158K
Operating cash flow$191K

Drawing the Sankey…

Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF

What changed this quarter

Revenue was $15.3M in Q2 2026, down 25% year over year and up 18% from the previous quarter. Consumer Products was the largest line at 93% of revenue. Consumer Products lost $3.3M year over year (down 19%), 66% of the total change.

Gross margin was 31.0%, down 0.7 points from Q2 2025. Operating profit was $121K, a 0.8% margin (down 11.4 points year over year). Operating expenses grew 17% against a revenue fall of 25%. The fastest-growing cost line was SG&A (+22%). The quarter ended with a net loss of $158K, narrower than the previous quarter's $1.0M loss. Net interest and other expense of $279K was the main reason.

Operating cash flow was $191K. Non-cash charges added back $323K of depreciation and amortization and $79K of share-based compensation. Working capital and other items used $53K.

Quarterly history

Solesence revenue by quarterSolesence revenue by quarter$12.6MQ4 2024$14.6MQ1 2025$20.4MQ2 2025$14.6MQ3 2025$12.5MQ4 2025$13.0MQ1 2026$15.3MQ2 2026
Solesence net earnings by quarterSolesence net earnings by quarter−$558KQ4 2024$80KQ1 2025$2.7MQ2 2025−$1.1MQ3 2025$163KQ4 2025−$766KQ1 2026−$158KQ2 2026
QuarterFormFiledRevenueY/YOp. marginNet earningsOp. cash flow
Q2 202610-QAug 19, 2026$15.3M-25%0.8%−$158K$191K
Q1 202610-QMay 12, 2026$13.0M-11%-3.9%−$766K$1.5M
Q4 202510-KMar 31, 2026$12.5M-0.7%1.5%$163K$1.8M
Q3 202510-QNov 12, 2025$14.6M-14%-5.4%−$1.1M−$2.5M
Q2 202510-QAug 14, 2025$20.4M+56%9.4%$2.7M−$654K
Q1 202510-QMay 13, 2025$14.6M+48%1.8%$80K−$7.2M
Q4 202410-KMar 31, 2025$12.6M+57%-1.8%−$558K$2.2M

Charts

Solesence: revenue growth, year over year and quarter over quarterSolesence: revenue growth, year over year and quarter over quarterY/YQ/Q+57%Q4 2024+48%+16%Q1 2025+56%+39%Q2 2025-14%-28%Q3 2025-1%-14%Q4 2025-11%+4%Q1 2026-25%+18%Q2 2026
Latest (Q2 2026): Y/Y -25%, Q/Q +18%.
Solesence: where the cash came from (+) and went (−), TTM to Q2 2026Solesence: where the cash came from (+) and went (−), TTM to Q2 2026Cash drawn (+) / kept (−)$3.1MOther financing−$2.3MOther investing−$1.9MOperating cash flow$1.0MShares issued$100K
From the cash-flow statement as filed (SEC XBRL). Cash is fungible: the bars do not say which dollar paid for what.
Solesence: profit against cash, quarter by quarterSolesence: profit against cash, quarter by quarterNet incomeOperating cash flow$3.0M$4.2MQ3 2024−$558K$2.2MQ4 2024$343K−$7.2MQ1 2025$3.2M−$654KQ2 2025−$1.1M−$2.5MQ3 2025$163K$1.8MQ4 2025−$962K$1.5MQ1 2026−$158K$191KQ2 2026
Latest (Q2 2026): Net income −$158K, Operating cash flow $191K.
Solesence: diluted shares by fiscal yearSolesence: diluted shares by fiscal year39MFY202047MFY202149MFY202250MFY202365MFY202473MFY2025
+88.3% since FY2020: more shares outstanding (issuance, stock pay).
Solesence in its industry: growth against margin (15 companies, SIC 2844)Solesence in its industry: growth against margin (15 companies, SIC 2844)revenue growth, year over year →↑ operating marginmedian +3%median 7%CLKVUEELCOTYEPCELFIPARAXILYCBDUGBNKKDQWSKARXSHFHSLSN (-25%, 1%)
Perfumes, Cosmetics & Other Toilet Preparations; dot size is quarterly revenue; dashed lines are the industry's medians.

Interactive views

The same charts as the app — open one to draw it.

💵Where each $1 goesinteractive

Loading the interactive chart…

🌏Named in Asian annual reportsinteractive

Loading the interactive chart…

🔄Rotation against the market and its industry (RRG)interactive

Loading the interactive chart…

🔍Earnings qualityinteractive

Loading the interactive chart…

⚖️Fair value by methodinteractive

Loading the interactive chart…

🔭Outlook & guidanceinteractive

Loading the interactive chart…

📈Investments: gains and what it boughtinteractive

Loading the interactive chart…

🏭Its industry’s money flow (input-output)interactive

Loading the interactive chart…

Solesence against its Perfumes, Cosmetics & Other Toilet Preparations peers

The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: -25% against the peers' median +2%. Operating margin: 0.8% against the peers' median 11.0%.

CompanyQuarterRevenueY/YOp. margin
SLSN SolesenceQ2 2026$15.3M-25%0.8%
CL Colgate PalmoliveQ3 2026$5.4B+5%20.3%
KVUE KenvueQ3 2026$3.9B+3%18.2%
EL Estee Lauder CompaniesQ1 FY27$3.7B+7%11.0%
COTY CotyQ1 FY27$1.6B-1%11.0%
EPC Edgewell Personal CareQ3 FY26$570M+2%4.4%
ELF e.l.f. BeautyQ2 FY27$521M+51%10.1%
IPAR InterparfumsQ3 2026$430M0%27.4%
AXIL Axil BrandsQ1 FY27$6.1M-11%7.2%

Source: Solesence 10-Q on SEC EDGAR · CIK 883107 · Perfumes, Cosmetics & Other Toilet Preparations

13F: who owns SLSN and who is buying

Largest holders of SLSN (13F)Largest holders of SLSN (13F)Vanguard Group$1.7MVanguard Capital Management LLC$610KBlackRock$341KBank of New York Mellon$233KMillennium Management LLC$203KGeode Capital Management, LLC$175KMorgan Stanley$139KDonaldson Capital Management, LLC$110KSusquehanna International Group, …$82KVanguard Fiduciary Trust$78K
Funds' net buying of SLSN by quarter (13F)Funds' net buying of SLSN by quarter (13F)$02024-12$02025-03$15.8M2025-06−$1.2M2025-09$568K2025-12$41K2026-03−$392K2026-06
Value of shares 13F filers added minus the value they sold, each quarter (quarters with most filings in).

More on SLSN

History

Every quarter: Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results · Q2 2025 results · Q1 2025 results · Q4 2024 results

Compare SLSN with

中文版:Solesence(SLSN)财报

Español · Français